Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer
- UPSpace Home
- →
- Health Sciences
- →
- Nuclear Medicine
- →
- Research Articles (Nuclear Medicine)
- →
- View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.
| dc.contributor.author | Lawal, Ismaheel Opeyemi
|
|
| dc.contributor.author | Morgenstern, Alfred
|
|
| dc.contributor.author | Vorster, Mariza
|
|
| dc.contributor.author | Knoesen, Otto
|
|
| dc.contributor.author | Mahapane, Johncy
|
|
| dc.contributor.author | Hlongwa, Khanyisile N.
|
|
| dc.contributor.author | Maserumule, Letjie C.
|
|
| dc.contributor.author | Ndlovu, Honest
|
|
| dc.contributor.author | Reed, Janet D.
|
|
| dc.contributor.author | Popoola, Gbenga O.
|
|
| dc.contributor.author | Mokoala, Kgomotso M.G.
|
|
| dc.contributor.author | Mdlophane, A.H.
|
|
| dc.contributor.author | Bruchertseifer, Frank
|
|
| dc.contributor.author | Sathekge, Mike Machaba
|
|
| dc.date.accessioned | 2022-07-22T08:53:13Z | |
| dc.date.issued | 2022-08 | |
| dc.description.abstract | Please read abstract in the article. | en_US |
| dc.description.department | Nuclear Medicine | en_US |
| dc.description.department | Radiography | en_US |
| dc.description.embargo | 2023-04-06 | |
| dc.description.librarian | dm2022 | en_US |
| dc.description.uri | https://www.springer.com/journal/259 | en_US |
| dc.identifier.citation | Lawal, I.O., Morgenstern, A., Vorster, M. et al. Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging 49, 3581–3592 (2022). https://doi.org/10.1007/s00259-022-05778-w. | en_US |
| dc.identifier.issn | 1619-7089 (online) | |
| dc.identifier.issn | 1619-7070 (print) | |
| dc.identifier.other | 10.1007/s00259-022-05778-w | |
| dc.identifier.uri | https://repository.up.ac.za/handle/2263/86396 | |
| dc.language.iso | en | en_US |
| dc.publisher | Springer | en_US |
| dc.rights | © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022. The original publication is available at : https://www.springer.com/journal/259. | en_US |
| dc.subject | Targeted alpha therapy | en_US |
| dc.subject | Superscan | en_US |
| dc.subject | Skeletal metastases | en_US |
| dc.subject | Prostate cancer | en_US |
| dc.subject | Hematologic toxicity | en_US |
| dc.subject | Metastatic castration-resistant prostate cancer (mCRPC) | en_US |
| dc.subject | Actinium-225-labeled prostate-specific membrane antigen ([225Ac]Ac-PSMA-617) | en_US |
| dc.title | Hematologic toxicity profile and efficacy of [225Ac]Ac-PSMA-617 α-radioligand therapy of patients with extensive skeletal metastases of castration-resistant prostate cancer | en_US |
| dc.type | Postprint Article | en_US |
